Implementation and Evaluation of a Before School Physical Activity Program in Revere, MA

December 19, 2025 updated by: Elsie Taveras, MD, Massachusetts General Hospital
This study evaluates the implementation of the BOKS program in three schools (K-8) in Revere, MA, and its effect on participating students with regard to BMI, cognitive, and quality of life outcomes. BOKS (Build Our Kids' Success) is a before-school physical activity program that has been implemented in over 2,000 elementary and middle schools. Two sessions will be held (Spring 2018 and Winter 2018. This is a cohort study evaluating the impact of program participation on child BMI, quality of life, and executive function.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

188

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 10 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Enrolled in the BOKS program
  • Participating school
  • Age 5-14

Exclusion Criteria:

  • No valid consent
  • Not enrolled in BOKS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Spring 2018 Participation
Students in this arm (40 per school, up to 120 total) will participate in the BOKS program in Winter-Spring 2018. They will serve as the control group in Fall 2018.
Other: BOKS Program
12-week physical activity program, occurring 3x/week, lasting 30-60 minutes per session.
Experimental: Fall 2018 Participation
Students in this arm (40 per school, up to 120 total) will participate in the BOKS program in Fall 2018.
Other: BOKS Program
12-week physical activity program, occurring 3x/week, lasting 30-60 minutes per session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Mass Index (kg/m^2)
Time Frame: Baseline, Follow-up for each session (12 weeks)
calculated from height and weight
Baseline, Follow-up for each session (12 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Executive Function
Time Frame: Baseline, Follow-up for each session (12 weeks)
Executive function and attention/concentration as measured by the Flanker Task
Baseline, Follow-up for each session (12 weeks)
Change in Quality of Life PedsQL
Time Frame: Baseline, Follow-up for each session (12 weeks)
Measured by PedsQL, a validated measure of pediatric self-rated quality of life with higher score indicating higher quality of life.
Baseline, Follow-up for each session (12 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Massachusetts General Hospital

Collaborators

American Council on Exercise
BOKS

Investigators

  • Principal Investigator: Elsie Taveras, MD, MGH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2018

Primary Completion (Actual)

December 30, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

January 11, 2019

First Submitted That Met QC Criteria

January 14, 2019

First Posted (Actual)

January 15, 2019

Study Record Updates

Last Update Posted (Estimated)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017P002770

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe